Developments PolyPid D-PLEX100 gets FDA breakthrough therapy designation The FDA granted PolyPid’s (NASDAQ:PYPD) D-PLEX100 breakthrough therapy designation for the prevention of surgical site infections in patients undergoing colorectal surgery. D-PLEX100 is designed to provide prolonged... November 24, 2020